Please note that documents represented the latest scientific and technical findings and complied with the applicable legal requirements at the moment of their publication. After they have been published under “Latest news” and “Communications” on specific topics relating to complementary and herbal medicine, they will be moved to the Archive in due course so that they remain available as a compilation of information. Archived documents are not updated.

The current legislation and the latest scientific and technical findings are authoritative.


Amino AG/Dr. Heinz Welti AG: Suspension of establishment licences and authorisations

Medicinal products that have already been delivered can still be distributed


Aufsichtsabgabe 2022 – Selbstdeklaration

Eingabefrist: 20. Januar 2023


Die neue Pharmacopoea Helvetica 12

Die neue Pharmacopoea Helvetica ist publiziert. Der Institutsrat hat beschlossen, die 12. Ausgabe der Schweizerischen Pharmakopöe auf den 1. April 2023 in Kraft zu setzen.


Batch recall – Cassis Halspastillen, Lutschtabletten

Rückruf der Charge L2117 bis auf Stufe Patient


Batch recall – Rubimed Staphisagria comp., Dilution 50ml

Rückruf der Charge 21711 bis auf Stufe Detailhandel


Guidance document Authorisation according to Art. 14 para. 1 abis-quater TPA HMV4 updated

Clarification of safety-relevant updates to medicinal product information for authorisations according to Art. 14 para. 1 let. abis TPA


Swissmedic information event «Regulatory & Beyond»

Registration deadline expired
20 September 2022, Bern, 9.00 a.m. to 5.30 p.m.


Benchmarking study 2021

International comparison of Swiss approval times


New website – complementary and herbal medicines (CHM)

The website for authorisation of complementary and herbal medicines has been completely revised and updated

Last modification 10.08.2022

Top of page